Advanced Technology and Business Portal – Intel Xeon and A.I. Powered

Health & Technology

Alzheimer’s drug study yields positive results, say makers Eisai and Biogen

1 min read

4 years ago Curated by John Wysocki

Advertisements

Sept 27 (Reuters) – An experimental Alzheimer’s drug made by Eisai Co Ltd (4523.T) and Biogen (BIIB.O) slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, they said on Tuesday, potentially a rare win in a field littered with failed drugs. […]

Click here to view original web page at www.reuters.com

Advertisements

Curated by John Wysocki Chief Technical Officer

Tags: 1800-patient trial Alzheimer’s Alzheimer’s drug Biogen brain-swelling Eisai intravenous antibody lecanemab Mayo Clinic Medicare micro hemorrhages needs FDA approval removes amyloid deposits side effects slowed progress by 27%

Medicare’s AI Prior Authorization Pilot Had 4 of 6 Vendors Flagged in First Weeks, Records Show Medicare’s AI Prior Authorization Pilot Had 4 of 6 Vendors Flagged in First Weeks, Records Show

1 min read

Health & Technology

Medicare’s AI Prior Authorization Pilot Had 4 of 6 Vendors Flagged in First Weeks, Records Show

6 days ago Curated by John Wysocki

OpenAI Hit With Stack of Lawsuits Over ChatGPT Allegedly Coaching Children to Harm Themselves OpenAI Hit With Stack of Lawsuits Over ChatGPT Allegedly Coaching Children to Harm Themselves

1 min read

Health & Technology

OpenAI Hit With Stack of Lawsuits Over ChatGPT Allegedly Coaching Children to Harm Themselves

4 weeks ago Curated by Theresa Wysocki

Global Experts Identify 17 “Catastrophic” Threats To Human Health This Century – Including 2 With “Extinction Potential” Global Experts Identify 17 “Catastrophic” Threats To Human Health This Century – Including 2 With “Extinction Potential”

1 min read

Health & Technology

Global Experts Identify 17 “Catastrophic” Threats To Human Health This Century – Including 2 With “Extinction Potential”

1 month ago Curated by Theresa Wysocki